ijddr

International Journal of Drug Development and Research

ISSN - 0975-9344

- (2015) Volume 7, Issue 3

Fluconazole Loaded Cubosomal Vesicles for Topical Delivery

 

Author info »

Abstract

Background: The present study involved formulation and evaluation of fluconazole loaded, self-assembled cubosomal gel developed for the treatment of fungal infections of the skin. The objective was to encapsulate high drug payload in cubosomes for improved therapeutic efficiency. Cubosomes were prepared by top down technique (Fragmentation by using sonication). Different formulations were prepared and optimized for better performance in terms of entrapment efficiency, vesicle size and permeation.

Methods: Studies were designed to formulate cubosomes by optimizing the ratio of the different components (GMO:P407:Water). The characterization and evaluation of the optimized cubosomal gel of fluconazole was carried out by Transmission Electron Microscopy (TEM), entrapment efficiency analysis, particle size distribution, drug permeability, rheology, texture analysis and in vitro antifungal activity. The prepared cubosomal gel of fluconazole was compared with the marketed Flucose® Gel for various rheological parameters.

Results: Data revealed the internal cubic structure of the vesicles. The optimized cubosomal dispersion exhibited good entrapment efficiency (78.79%) along with high drug permeability (88.54%). When compared to marketed formulation Flucose® Gel, it was observed that cubosomal gel presented better results and increased the permeability flux of fluconazole by 1.6 folds.

Conclusion: These results indicated that GMO based cubosomal system may serve as a potential topical delivery system for fluconazole and other drugs with similar partition coefficient values. It was also observed that cubosomal formulation enhanced drug payload and permeability across the skin.

References

  1. Novelli V, Holzel H (1999) Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother 43: 1955-1960.
  2. Magrath GN, Pulido JS, Montero J, Mason C, Wilson J (2010) Cystoid macular edema secondary to fluconazole toxicity. OculImmunolInflamm 18: 472-474.
  3. Andriole VT (1999) The 1998 Garrod lecture. Current and future antifungal therapy: new targets for antifungal agents. J AntimicrobChemother 44: 151-162.
  4. Cousin L, Berre ML, Launay-Vacher V, Izzedine H, Deray G (2003) Dosing guidelines for fluconazole in patients with renal failure. Nephrol Dial Transplant 18: 2227-2231.
  5. Mathias NR, Hussain MA (2010) Non-invasive systemic drug delivery: developability considerations for alternate routes of administration. J Pharm Sci 99: 1-20.
  6. Salerno C, Carlucci AM, Bregni C (2010) Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech 11: 986-993.
  7. Bennett PN, Brown MJ (2008) Viral, fungal, protozoal and helminthic infections. In Clinical Pharmacology. New York.
  8. Patel VR, Agrawal YK (2011) Nanosuspension: An approach to enhance solubility of drugs. J Adv Pharm Technol Res 2: 81-87.
  9. Larson K (1989) Cubic lipid-water phases: structures and biomembrane aspects. J PhysChemA 93: 7304-7314.
  10. Siekmann B, Bunjes H, Koch MH, Westesen K (2002) Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases. Int J Pharm 244: 33-43.
  11. Garg G, Saraf S, Saraf S (2007) Cubosomes: an overview. Biol Pharm Bull 30: 350-353.
  12. Schwarz JA, Contescu C, Putyera K (2003) Cubosomes: bicontinuous cubic liquid crystalline nanostructured particles. New York, USA.
  13. Prashar D, Sharma D (2011) Cubosomes: A Sustained drug delivery carrier. Asian J Res Pharm Sci 1: 59-62.
  14. Guo C, Wang J, Cao F, Lee RJ, Zhai G (2010) Lyotropic liquid crystal systems in drug delivery. Drug Discov Today 15: 1032-1040.
  15. Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S (2009) Liquid crystalline systems of phytantriol and glycerylmonooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. J Pharm Sci 98: 4191-4204.
  16. Singh A, Sharma PK, Majumdar DK (2011) Development and validation of different UV- spectrophotometric methods for the estimation of fluconazole in bulk and in solid dosage form. Indian J ChemTechnol 18: 357-362.
  17. Alvarenga L, Ferreira D, Altekruse D, Menezes JC, Lochmann D (2008) Tablet identification using near-infrared spectroscopy (NIRS) for pharmaceutical quality control. J Pharm Biomed Anal 48: 62-69.
  18. Baertschi SW, Alsante KM, Tønnesen HH (2010) A critical assessment of the ICH guideline on photostability testing of new drug substances and products (Q1B): Recommendation for revision. J Pharm Sci 99: 2934-2940.
  19. Baka E, Comer JE, Takács-Novák K (2008) Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 46: 335-341.
  20. Thadanki M, Kumari PS, Prabha KS (2011) Overview of cubosomes: A nano particle. IJRPC 1: 535-541.
  21. Yang Z, Tan Y, Chen M, Dian L, Shan Z, et al. (2012) Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability. AAPS PharmSciTech 13: 1483-1491.
  22. Esposito E, Eblovi N, Rasi S, Drechsler M, Di Gregorio GM, et al. (2003) Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci 5: E30.
  23. Pyrz WD, Buttrey DJ (2008) Particle size determination using TEM: a discussion of image acquisition and analysis for the novice microscopist. Langmuir 24: 11350-11360.
  24. Thapa RK, Baskaran R, Madheswaran T, Kim JO, Yong CS, et al. (2012) In vitro release and skin permeation of tacrolimus from monoolein-based liquid crystalline nanoparticles. J Drug Del Sci Tech 22: 479-484.
  25. Fang JY, Leu YL, Chang CC, Lin CH, Tsai YH (2004) Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Deliv 11: 97-105.
  26. Mitkari BV, Korde SA, Mahadik KR, Kokare CR (2010) Formulation and evaluation of topical liposomal gel for fluconazole. Indian J Pharm Educ Res 44: 324-333.
  27. Plaizier-Vercammen JA, Lecluse E, Boute P, De Neve RE (1989) Rheological properties of topical fluoride gels. Dent Mater 5: 301-305.
  28. Kumar L, Verma R (2011) Chemical stability studies of bioadhesive topical gel. Int J Pharm PharmSci 3: 101-104.
  29. Higuchi T (1963) Mechanism of Sustained-Action Medication. Theoretical Analysis of Rate of Release of Solid Drugs Dispersed in Solid Matrices. J Pharm Sci 52: 1145-1149.
  30. Kirkpatrick WR, Turner TM, Fothergill AW, McCarthy DI, Redding SW, et al. (1998) Fluconazole disk diffusion susceptibility testing of Candida species. J ClinMicrobiol 36: 3429-3432.
  31. Pavia DL, Lampman GM, Kriz GS (2001) Introduction to spectroscopy. USA: Thomsan learning.
  32. Stat-Ease. Design Expert® In: Minneapolis MNS-E, Inc., editor. v 8.0.1(Trial version) ed. USA; 2010.
  33. Daniel W (1983) Biostatistics: A foundation for analysis in the health sciences. Analysis of Variance. 3rd edn. New York: John Wiley and Sons.
  34. Tanojo H, Bouwstra JA, Junginger HE, Boddé HE (1997) In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm Res 14: 42-49.
  35. Elyan BM, Sidhom MB, Plakogiannis FM (1996) Evaluation of the effect of different fatty acids on the percutaneous absorption of metaproterenol sulfate. J Pharm Sci 85: 101-105.
  36. Windle AH (1985) Case II Sorption in polymer permeability. Polymer Permeability 75-118.
  37. Jacques CHM, Hopfenberg HB, Stannet VT (1973) Vapor Sorption and Liquid Interactions with Glassy Polyblends of Polystyrene and Poly (2,6-Dimethyl-1,4-Phenylene Oxide). PolymEngSci 13:81-87.
  38. Larson E (1988) Guideline for use of topical antimicrobial agents. Am J Infect Control 16: 253-266.

Author Info

 

Copyright:This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.